Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Rises By 284.7%

Posted by Doug Madison on Dec 13th, 2024

Biomerica, Inc. (NASDAQ:BMRA – Get Free Report) was the recipient of a significant increase in short interest in November. As of November 30th, there was short interest totalling 1,430,000 shares, an increase of 284.7% from the November 15th total of 371,700 shares. Based on an average daily volume of 844,900 shares, the short-interest ratio is presently 1.7 days.

Biomerica Trading Down 0.6 %

BMRA traded down $0.00 during midday trading on Friday, hitting $0.29. The company had a trading volume of 46,430 shares, compared to its average volume of 406,064. Biomerica has a 52 week low of $0.24 and a 52 week high of $2.13. The stock’s 50 day moving average price is $0.34 and its 200 day moving average price is $0.38.

Biomerica (NASDAQ:BMRA – Get Free Report) last posted its quarterly earnings results on Tuesday, October 15th. The company reported ($0.08) earnings per share for the quarter. Biomerica had a negative net margin of 111.89% and a negative return on equity of 84.62%. The company had revenue of $1.81 million during the quarter.

Institutional Investors Weigh In On Biomerica

An institutional investor recently bought a new position in Biomerica stock. Perritt Capital Management Inc bought a new position in shares of Biomerica, Inc. (NASDAQ:BMRA – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 70,000 shares of the company’s stock, valued at approximately $31,000. Perritt Capital Management Inc owned approximately 0.42% of Biomerica at the end of the most recent reporting period. Hedge funds and other institutional investors own 22.28% of the company’s stock.

Biomerica Company Profile

(Get Free Report)

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.